ENVESTNET ASSET MANAGEMENT INC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 259 filers reported holding HAEMONETICS CORP in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$3,018,891
+29.1%
33,701
+22.7%
0.00%0.0%
Q2 2023$2,338,796
+11.8%
27,470
-93.2%
0.00%0.0%
Q1 2023$2,091,480
-6.1%
406,531
+1335.9%
0.00%0.0%
Q4 2022$2,226,739
+10.5%
28,312
+4.0%
0.00%0.0%
Q3 2022$2,016,000
+27.8%
27,234
+12.6%
0.00%0.0%
Q2 2022$1,577,000
+0.9%
24,189
-2.1%
0.00%0.0%
Q1 2022$1,563,000
+92.7%
24,716
+61.6%
0.00%
Q4 2021$811,000
-29.0%
15,299
-5.5%
0.00%
-100.0%
Q3 2021$1,143,000
-10.6%
16,189
-15.6%
0.00%0.0%
Q2 2021$1,278,000
-62.3%
19,175
-37.3%
0.00%
-50.0%
Q1 2021$3,394,000
-4.2%
30,572
+2.5%
0.00%
-33.3%
Q4 2020$3,542,000
+67.2%
29,824
+22.8%
0.00%
+50.0%
Q3 2020$2,118,000
+46.6%
24,279
+50.4%
0.00%
+100.0%
Q2 2020$1,445,000
+7.7%
16,139
+19.9%
0.00%
-50.0%
Q1 2020$1,342,000
+15.6%
13,464
+33.2%
0.00%
+100.0%
Q4 2019$1,161,000
-4.0%
10,105
+5.3%
0.00%0.0%
Q3 2019$1,210,000
+98.4%
9,594
+89.1%
0.00%0.0%
Q2 2019$610,000
+81.0%
5,073
+31.7%
0.00%
Q1 2019$337,000
-76.4%
3,852
-73.0%
0.00%
-100.0%
Q4 2018$1,430,000
-11.6%
14,293
-20.8%
0.00%
-50.0%
Q2 2018$1,618,000
-14.8%
18,049
-30.5%
0.00%
-20.0%
Q1 2018$1,899,000
+22.6%
25,955
-2.7%
0.01%
+66.7%
Q4 2017$1,549,000
+29.8%
26,665
+0.3%
0.00%0.0%
Q3 2017$1,193,000
+3.8%
26,572
-8.8%
0.00%0.0%
Q2 2017$1,149,000
+11.8%
29,140
+14.9%
0.00%0.0%
Q1 2017$1,028,000
+1.7%
25,371
+0.9%
0.00%
-25.0%
Q4 2016$1,011,000
+10.3%
25,146
-0.7%
0.00%0.0%
Q3 2016$917,000
+24.8%
25,329
-0.0%
0.00%
+33.3%
Q2 2016$735,000
-25.2%
25,337
-9.8%
0.00%
-25.0%
Q1 2016$982,000
+19.8%
28,087
+10.5%
0.00%0.0%
Q4 2015$820,000
-4.3%
25,429
-4.1%
0.00%0.0%
Q3 2015$857,000
-30.7%
26,526
-11.3%
0.00%
-33.3%
Q2 2015$1,237,000
-22.5%
29,899
-15.8%
0.01%
-25.0%
Q1 2015$1,596,000
+7154.5%
35,530
+5891.6%
0.01%
Q4 2014$22,000
+4.8%
5930.0%0.00%
Q3 2014$21,000
+10.5%
593
+11.9%
0.00%
Q2 2014$19,000
+90.0%
530
+71.5%
0.00%
Q1 2014$10,000
-63.0%
309
-52.5%
0.00%
Q4 2013$27,000
+80.0%
650
+68.0%
0.00%
Q3 2013$15,000
-25.0%
387
-19.9%
0.00%
Q2 2013$20,0004830.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders